Literature DB >> 18631333

Long-term visual prognosis of corneal and ocular surface surgery in patients with congenital aniridia.

María Fideliz de la Paz1, Juan Alvarez de Toledo, Rafael Ignacio Barraquer, Joaquín Barraquer.   

Abstract

PURPOSE: To evaluate the long-term visual prognosis of corneal and ocular surface surgery in patients with congenital aniridia.
METHODS: Retrospective comparative interventional case series on 88 eyes of 45 patients with congenital aniridia treated and/or operated on from 1956 to present. Corneal and ocular surface findings were identified and patients were classified into operated (group I) or not operated (group II). Long-term best-ever best-corrected visual acuity (BCVA), final BCVA and long-term delta BCVA (long-term best-ever BCVA - final BCVA) were recorded and compared between the two groups, and between the limbal transplant (LT) (group I-A) and the penetrating keratoplasty (PK) (group I-B) patients. Postoperative results were also compared.
RESULTS: Limbal insufficiency was present in 58% of eyes and dense central corneal opacities were present in 27% of eyes. As a primary surgery, limbal allograft was performed in 10 eyes and PK in 13 eyes. The mean long-term follow-up times were 23 years in group I and 16 years in group II. The mean long-term delta BCVA was 0.032 in group I and 0.028 in group II. Comparisons of the VA means were insignificant (long-term best-ever, final BCVA and long-term delta BCVA). When comparing the LT and PK groups, mean long-term delta BCVA was 0.0328 in group I-A and 0.0382 in group I-B. Mean postoperative delta BCVA was 0.028 in group I-A and 0.048 in group I-B. We found no statistical significance between the LT and the PK groups as regards long-term postoperative BCVA results.
CONCLUSION: Long-term visual prognosis does not differ whether or not the patient undergoes surgery for aniridic keratopathy. LT and PK have comparable results over 5 years of follow-up because of the eventual failure of transplanted allografts.

Entities:  

Mesh:

Year:  2008        PMID: 18631333     DOI: 10.1111/j.1755-3768.2008.01293.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  7 in total

1.  Congenital aniridia: long-term clinical course, visual outcome, and prognostic factors.

Authors:  Ji Woong Chang; Jeong Hun Kim; Seong-Joon Kim; Young Suk Yu
Journal:  Korean J Ophthalmol       Date:  2014-11-19

2.  Topical bevacizumab treatment in aniridia.

Authors:  Ruth Lapid-Gortzak; Nathalie T Y Santana; Carla P Nieuwendaal; Maarten P Mourits; Ivanka J E van der Meulen
Journal:  Int Ophthalmol       Date:  2017-06-15       Impact factor: 2.031

3.  Anatomical survival and visual prognosis of Boston type I keratoprosthesis in challenging cases.

Authors:  Maria Fideliz de la Paz; Josef Stoiber; Valeria de Rezende Couto Nascimento; Juan Alvarez de Toledo; Orang Seyeddain; Wolfgang Hitzl; Günther Grabner; Rafael I Barraquer; Ralph Michael
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-25       Impact factor: 3.117

4.  Aniridia-related keratopathy: Structural changes in naïve and transplanted corneal buttons.

Authors:  André Vicente; Berit Byström; Mona Lindström; Ulf Stenevi; Fátima Pedrosa Domellöf
Journal:  PLoS One       Date:  2018-06-11       Impact factor: 3.240

5.  Quantitative Analysis of the Association Between Follow-Up Duration and Severity of Limbal Stem Cell Deficiency or Visual Acuity in Aniridia.

Authors:  Shimpei Komoto; Yoshinori Oie; Satoshi Kawasaki; Ryo Kawasaki; Nozomi Nishida; Takeshi Soma; Shizuka Koh; Kazuichi Maruyama; Shinichi Usui; Kenji Matsushita; Motokazu Tsujikawa; Naoyuki Maeda; Kohji Nishida
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-06-03       Impact factor: 4.799

6.  Congenital aniridia: clinical profile of children seen at the University College Hospital, Ibadan, South-West Nigeria.

Authors:  Mary Ogbenyi Ugalahi; Folahan Adesola Ibukun; Bolutife Ayokunnu Olusanya; Aderonke Mojisola Baiyeroju
Journal:  Ther Adv Ophthalmol       Date:  2021-05-31

7.  Outcomes of Human Leukocyte Antigen-Matched Allogeneic Cultivated Limbal Epithelial Transplantation in Aniridia-Associated Keratopathy-A Single-Center Retrospective Analysis.

Authors:  Joséphine Behaegel; Marie-José Tassignon; Neil Lagali; Alejandra Consejo; Carina Koppen; Sorcha Ní Dhubhghaill
Journal:  Cornea       Date:  2022-01-01       Impact factor: 3.152

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.